1. Japan Stocks

  2. •

    Technology

  3. •

    Computer Hardware
Canon Inc.

Canon Inc.

7751.T
Canon Inc.JP flagTokyo Stock Exchange
4,288.00
JPY
-28.00
- -
3.72TMarket Cap
Canon Inc.
7751.T
(Tokyo Stock Exchange)

Recent

price

4,288.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
3,002.01
2,925.87
2,964.96
3,250.52
3,350.32
3,480.04
3,114.74
3,758.86
3,660.04
3,358.36
3,010.32
3,360.03
3,911.55
4,175.96
4,664.96
5,118.17
- -
Revenue per Share
199.71
204.49
191.34
200.78
229.03
201.65
137.95
222.88
233.8
116.79
79.37
205.35
236.71
264.2
165.53
367.48
- -
Basic EPS, GAAP
441.58
190.35
57.83
239.1
328.6
203.09
268.59
369.5
161.05
133.45
161.06
261.73
71.87
220.62
382.55
236.54
- -
Free Cash Flow per Basic Share
110.22
125.66
121.3
135.57
131.05
159.99
150
150.07
165
160.27
120.92
85.01
115.78
130.71
146.4
163.4
- -
Dividend per Share
2,542.91
2,659.91
2,823.47
2,950.91
3,141.7
3,241.63
3,228.29
3,320.38
3,411.59
3,392.52
3,414.1
3,550.77
3,725.34
3,971.21
4,130.81
4,623.01
4,309.93
Book Value per Share
2,151.44
2,118.38
2,231.15
2,545.18
2,473.82
2,256.66
1,476.04
1,601.64
1,591.46
1,530.34
1,476.45
1,762.36
2,033.11
2,282.63
2,538.84
2,798.46
2,422.28
Tangible Book Value per Share
1,235
1,216
1,174
1,148
1,113
1,092
1,092
1,085
1,080
1,070
1,050
1,046
1,031
1,001
967
904
945
Basic Weighted Avg Shares
3,706,901
3,557,433
3,479,788
3,731,380
3,727,252
3,800,271
3,401,487
4,080,015
3,951,937
3,593,299
3,160,243
3,513,357
4,031,414
4,180,972
4,509,821
4,624,727
- -
Sales/Revenue/Turnover
10.45
10.63
9.31
9.04
9.75
9.35
6.36
8.71
8.67
4.85
3.5
8.02
8.77
8.98
9.86
9.85
- -
Operating Margin (%)
276,193
261,343
258,133
275,173
263,480
273,327
250,096
261,881
251,554
237,327
227,825
221,246
226,492
238,676
235,465
239,236
- -
Depreciation Expense
246,603
248,630
224,564
230,483
254,797
220,209
150,650
241,923
252,441
124,964
83,318
214,718
243,961
264,513
160,025
332,053
- -
Net Income, GAAP
35.68
32.15
32.14
31.1
30.79
33.42
33.8
27.7
26.49
28.72
26.36
23.74
26.2
27.21
39.28
25.7
- -
Effective Tax Rate (%)
6.65
6.99
6.45
6.18
6.84
5.79
4.43
5.93
6.39
3.48
2.64
6.11
6.05
6.33
3.55
7.18
- -
Profit Margin (%)
1,233,488
1,259,457
1,237,821
1,437,635
1,470,554
1,241,850
1,116,379
1,123,169
1,020,527
873,962
462,954
817,512
790,561
784,910
903,777
912,961
812,087
Working Capital
4,131
3,368
2,117
1,448
1,148
881
611,289
493,238
361,962
441,028
81,630
245,135
87,748
95,558
303,294
391,924
390,317
LT Debt
2,809,637
2,713,667
2,754,302
3,066,777
3,140,758
3,184,463
2,994,622
3,096,175
3,017,913
2,883,980
2,784,041
3,098,429
3,349,030
3,605,707
3,645,051
3,774,128
3,481,054
Total Equity
8.55
9.08
7.9
7.86
7.99
7.38
4.18
7.02
7.05
3.63
2.43
6.37
7.18
6.83
6.31
7.38
- -
Return on Invested Capital (%)
7.37
7.25
6.32
6.32
6.79
5.65
3.45
5.25
5.54
2.58
1.65
4.65
5.22
5.33
2.88
6.03
- -
Return on Capital (%)
7.97
7.8
6.86
6.88
7.4
6.26
4.26
6.79
6.93
3.42
2.31
5.89
6.46
6.77
4.02
8.13
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
- -
- -
728,013
LT Borrowings
- -
- -
304,908
LT Finance Leases
- -
- -
85,409
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
- -
- -
902
Market Capitalization
4,988,413
4,428,307
3,959,185

Working Capital

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
- -
- -
2,645,227
Cash, Cash Equivalents & STI
- -
- -
721,994
Accounts Receivable, Net
- -
- -
639,785
Inventories
- -
- -
879,459
Total Current Liabilities
- -
- -
1,833,140
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
728,013
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
1.87%
6.33%
3.54%
Free Cash Flow
22.52%
42.47%
-42.21%
Net Income, GAAP
19.73%
49.55%
107.5%
Sales/Revenue/Turnover
2.52%
8.01%
2.55%
Total Cash Common Dividend
-0.07%
5.28%
4.32%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
988,519
1,167,786
- -
- -
4,509,821
2025
- -
- -
- -
- -
4,624,727
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
60.7
91.88
- -
- -
165.53
2025
- -
- -
- -
- -
367.48
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
70.01
- -
- -
- -
146.4
2025
- -
- -
- -
- -
163.4
2026
- -
- -
- -
- -
- -
Similar Companies
NEXCOM International Co., Ltd. (8234.TWO)
Biostar Microtech International Corp. (2399.TW)
TransAct Technologies Incorporated (TACT)
SOLIZE Corporation (5871.T)
TSG Development Co., Ltd. (3521.TWO)
JWIPC Technology Co., Ltd. (001339.SZ)
Business
Canon Inc. (7751.T), founded in 1937 and headquartered in Ota-ku, Tokyo, Japan, manufactures and sells optical, imaging, industrial, and medical equipment worldwide, operating through four principal segments: Printing, Imaging, Medical, and Industrial. The Printing Business Unit offers office multifunction devices, digital production printers, large-format inkjet printers, laser multifunction printers, inkjet printers, document scanners, and calculators; the Imaging Business Unit provides interchangeable-lens digital cameras, compact digital cameras, lenses, digital camcorders, compact photo printers, network cameras, video management software, and broadcast equipment; the Medical Business Unit supplies computed tomography systems, diagnostic ultrasound systems, X-ray systems, magnetic resonance imaging systems, digital radiography systems, ophthalmic equipment, in vitro diagnostic systems, reagents, and healthcare IT solutions; and the Industrial Business Unit delivers semiconductor lithography equipment, flat-panel display lithography equipment, OLED display manufacturing equipment, vacuum thin-film deposition equipment, and die bonders, with products marketed under the Canon brand across Japan, the Americas, Europe, Asia, Oceania, and the Middle East. The company maintains extensive global operations, including regional headquarters in the Americas, Europe, and Asia, and 336 consolidated subsidiaries as of late 2023. In recent developments, Canon U.S.A. announced a major restructuring in August 2024, consolidating sales operations into two unified divisions and merging Canon Solutions America into Canon U.S.A. effective January 1, 2025, to streamline efficiency and enhance competitiveness; Canon Medical completed the acquisition of Minaris Medical from Resonac in 2024, integrating in vitro diagnostic reagents and analyzers to bolster its diagnostics portfolio; and in 2025, Canon increased its stake toward full ownership in a key electronics subsidiary while advancing its imaging segment growth.